EUVIMEDEUVIMED entdecken
Open Access

PSMA-GCK01: A Generator-Based 99m Tc/ 188 Re Theranostic Ligand for the Prostate-Specific Membrane Antigen

Jens Cardinale, Frederik L Giesel, Christina Wensky, Hendrik G Rathke, Uwe Haberkorn, Clemens Kratochwil

Journal of Nuclear Medicine · 2023

DOI: 10.2967/jnumed.122.264944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2023. Verfasst von Jens Cardinale und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany; jens.cardinale@med.uni-duesseldorf.de. Hauptthemen laut MEDLINE: Precision Medicine, Prostatic Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate-specific membrane antigen (PSMA) theranostics have been introduced with 68Ga and 177Lu, the most used radionuclides. However, 188Re is a well-known generator-based therapeutic nuclide that completes a theranostic tandem with 99mTc and may offer an interesting alternative to the currently used radionuclides. In the present work, we aimed at the development of a PSMA-targeted 99mTc/188Re theranostic tandem.

Methods

The ligand HYNIC-iPSMA was chosen as the lead structure. Its HYNIC chelator has limitations for 188Re labeling and was replaced by mercaptoacetyltriserine to obtain PSMA-GCK01, a precursor for stable 99mTc and 188Re labeling. 99mTc-PSMA-GCK01 was used for in vitro evaluation of the ligand and comparison with 99mTc-EDDA/HYNIC-iPSMA. Planar imaging using 99mTc-PSMA-GCK01 and organ biodistribution with 188Re-PSMA-GCK01 were performed using LNCaP tumor-bearing mice. Finally, the theranostic tandem was applied for imaging and therapy in 3 prostate cancer patients in compassionate care.

Results

Efficient radiolabeling of PSMA-GCK01 with both radionuclides was demonstrated. Cell-based assays with 99mTc-PSMA-GCK01 versus 99mTc-EDDA/HYNIC-iPSMA revealed comparable uptake characteristics. Planar imaging and organ distribution revealed good tumor uptake of both 99mTc-PSMA-GCK01 and 188Re-PSMA-GCK01 at 1 and 3 h after injection, with low uptake in nontarget organs. In patients, similar distribution patterns were observed for 99mTc-PSMA-GCK01 and 188Re-PSMA-GCK01 and in comparison with 177Lu-PSMA-617.

Conclusion

The ligand PSMA-GCK01 labels stably with 99mTc and 188Re, both generator-based radionuclides, and thus provides access to on-demand labeling at reasonable costs. Preclinical evaluation of the compounds revealed favorable characteristics of the PSMA-targeted theranostic tandem. This result was confirmed by successful translation into first-in-humans application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineProstatic NeoplasmsMaleHumansAnimalsMiceTissue DistributionLigandsProstateRadioisotopesEdetic Acid

Stichwörter der Autor:innen

188Re99mTcPSMASPECTtheranostic

Substanzen

LigandsRadioisotopesEDDAEdetic Acid

Autor:innen und Institutionen

  • Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany; jens.cardinale@med.uni-duesseldorf.de.
  • Department of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Duesseldorf, Germany; and.
  • Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany.

Zitieren

APA

Cardinale, J., Giesel, F. L., Wensky, C., Rathke, H. G., Haberkorn, U., & Kratochwil, C. (2023). PSMA-GCK01: A Generator-Based 99m Tc/ 188 Re Theranostic Ligand for the Prostate-Specific Membrane Antigen. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.122.264944

Vancouver

Cardinale J, Giesel FL, Wensky C, Rathke HG, Haberkorn U, Kratochwil C. PSMA-GCK01: A Generator-Based 99m Tc/ 188 Re Theranostic Ligand for the Prostate-Specific Membrane Antigen. Journal of Nuclear Medicine. 2023. doi:10.2967/jnumed.122.264944

BibTeX
@article{Cardinale2023,
  author = {Cardinale, Jens and Giesel, Frederik L and Wensky, Christina and Rathke, Hendrik G and Haberkorn, Uwe and Kratochwil, Clemens},
  title = {PSMA-GCK01: A Generator-Based 99m Tc/ 188 Re Theranostic Ligand for the Prostate-Specific Membrane Antigen},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  doi = {10.2967/jnumed.122.264944}
}
Kostenlos starten →